Keven Faust, PA-C

Keven Faust practices at Next Level Urgent Care - Sugar Land (Kensington Dr) in Sugarland, Texas.

Keven Faust's NPI, 1811530397, was assigned on October 28, 2019.

Keven Faust's primary practice is Next Level Urgent Care - Sugar Land (Kensington Dr), at 16107 Kensington Dr, Sugarland, TX 77479. The practice phone is (281) 783-8162.

Keven Faust's primary practice is Next Level Urgent Care - Sugar Land (Kensington Dr) in Sugarland, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Keven Faust to 5 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Keven Faust practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Keven Faust's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

CMS data shows 702 Medicare services from Keven Faust across 10 procedure codes in 2024, for 186 Medicare patients. Medicare paid $29,280 for them. Every service was in an office.

CMS counts 186 Medicare patients who saw Keven Faust in 2024. The largest group is 65 to 74, with 87 patients. 72% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Keven Faust's median patient age at 60, with 52% women.

In 2024, Keven Faust wrote 83 Medicare Part D claims for 51 patients. 95% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $444 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Keven Faust for performance year 2024, reported as part of a group. Keven Faust accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 45 general payments to Keven Faust from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $279.